Status:
COMPLETED
Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury
Lead Sponsor:
University Hospital, Brest
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
18+ years
Brief Summary
Patients with moderate traumatic brain injury (mTBI) are 1,5 times more frequent than those with severe TBI and some of them will develop secondary neurologic deterioration (SND) within the first 7 da...
Eligibility Criteria
Inclusion
- Adults
- Admitted in Brest hospital between 2015 and 2018 for moderate TBI, defined by Glasgow coma scale (GCS) score 9-13
Exclusion
- Non consenting patients
Key Trial Info
Start Date :
February 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 22 2021
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04854954
Start Date
February 3 2021
End Date
March 22 2021
Last Update
April 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609